Pharmaceuticals.jpg

Pharmaceuticals

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

07/07/9002

Trypsine pancréatiqueporc

07/07/9002
61036-62-2

Teicoplanin

61036-62-2
5011-34-7

Trimetazidine

5011-34-7
163451-81-8

Teriflunomide

163451-81-8
23031-25-6

Terbutaline

23031-25-6
53885-35-1

Ticlopidine HCl

53885-35-1
26921-17-5

Timolol Maleate

26921-17-5
68786-66-3

Triclabendazole

68786-66-3
56211-40-6

Torasemide

56211-40-6
1684-40-8

Tacrine HCl

1684-40-8
89786-04-9

Tazobactam

89786-04-9
50679-08-8

Terfenadine

50679-08-8
328898-40-4

Tildipirosin

328898-40-4
69004-04-2

Toltrazuril Sulfone / Ponazuril

69004-04-2
53188-07-1

Trolox

53188-07-1
10379-14-3

Tetrazepam

10379-14-3
1018989-94-0

Tramadol N-desmethyl HCl

1018989-94-0
148262-77-5

Tramadol O-desmethyl HCl

148262-77-5
63409-10-9

Tylosin 3-Acetate

63409-10-9
202138-50-9

Tenofovir Disoproxil Fumarate

202138-50-9